R GAPDH RT-qPCR Mouse-TGTAGACCATGTAGTTGAGGTCA ( 50S,SaltFree) and 11 more items

Eurofins Genomics LLC was awarded a contract by the University of Virginia on June 25, 2026, to supply synthetic oligonucleotide primers for molecular research applications. The contract, identified as A207_PO-0452416, is valued at sixty-two dollars and covers twelve distinct line items consisting of human and mouse genetic primers targeting specific gene exons. The primers are salt-free, fifty-nucleotide sequences designed for quantitative reverse transcription polymerase chain reaction (RT-qPCR) and other molecular biology assays, with target genes including GTPBP2 (GTPase binding protein 2) and GAPDH (glyceraldehyde 3-phosphate dehydrogenase). All materials are to be delivered to Carolyn Sue Smith at the University of Virginia in Virginia.

Individual line item unit prices range from five dollars to five dollars and seventy-five cents per primer sequence, with each line item comprising a single unit order. The contract represents a small-value procurement typical of academic research support, procuring specialized research reagents for molecular biology experiments. No specific contract period of performance dates beyond the award date are provided in the available documentation.